
Cyrus V DeSouza MD
Diabetes, Lipid Metabolism
Associate Professor, Internal Medicine, University of Nebraska Medical Center College of Medicine
Join to View Full Profile
988095 Nebraska Medical CtrOmaha, NE 68198
Phone+1 402-559-9800
Fax+1 402-559-9840
Dr. DeSouza is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Tulane UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 2000 - 2002
- St Barnabas HospitalResidency, Internal Medicine, 1997 - 2000
- St. John's Medical CollegeClass of 1996
Certifications & Licensure
- NE State Medical License 2002 - 2026
- TX State Medical License 2009 - 2024
- LA State Medical License 2000 - 2004
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Fellow (FACE) American Association of Clinical Endocrinology
Clinical Trials
- Role of Apathy in the Effectiveness of Weight Loss Interventions Start of enrollment: 2007 Aug 01
- A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes Start of enrollment: 2013 May 01
- Vitamin D and Type 2 Diabetes Study Start of enrollment: 2013 Oct 01
Publications & Presentations
PubMed
- Weekly Fixed-Dose Insulin Efsitora in Type 2 Diabetes without Previous Insulin Therapy.Julio Rosenstock, Timothy Bailey, Lisa Connery, Eden Miller, Cyrus Desouza
The New England Journal of Medicine. 2025-06-22 - 1 citationsOral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial.Nikolaus Marx, John E Deanfield, Johannes F E Mann, Rosario Arechavaleta, Stephen C Bain
Circulation. 2025-06-10 - Factors Associated with Response to SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Veterans with Type 2 Diabetes Mellitus.Gunjan Arora, Sulman Hashmi, Samson Kaeli, Sarah Azad, Jaskaran Batra
Journal of Clinical Medicine. 2025-06-10
Journal Articles
- Effect of Behavioral Therapy with in-Clinic or Telephone Group Visits vs in-Clinic Individual Visits on Weight Loss Among Patients with Obesity in Rural Clinical PracticeCyrus Desouza, Alexandra R Brown, Leslie Eiland, JAMA
- A 26-Week Randomized Controlled Trial of Semaglutide Once Daily Versus Liraglutide and Placebo in Patients with Type 2 Diabetes Suboptimally Controlled on Diet and Exe...Ildiko Lingvay, Cyrus V Desouza, Diabetes Care
Grant Support
- TP-R: a novel mediator of obesity-linked insulin resistance in humansOMAHA VA MEDICAL CENTER2021–2026
- TP-R: a novel mediator of obesity-linked insulin resistance in humansOMAHA VA MEDICAL CENTER2021–2026
- TP-R: a novel mediator of obesity-linked insulin resistance in humansOMAHA VA MEDICAL CENTER2021–2026
- All of Us Research Program Heartland Consortium (AoURP-HC)UNIVERSITY OF KANSAS MEDICAL CENTER2023–2025
- All of Us Research Program Heartland Consortium (AoURP-HC)UNIVERSITY OF KANSAS MEDICAL CENTER2023–2025
- All of Us Research Program Heartland Consortium (AoURP-HC)UNIVERSITY OF KANSAS MEDICAL CENTER2023–2025
- All of Us Research Program Heartland Consortium (AoURP-HC)UNIVERSITY OF KANSAS MEDICAL CENTER2023–2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: